Quick Contact

Regional Strength

Regionally, the North-East is a major location for the pharmaceutical industry and in Tees Valley the health and life sciences sector is a key growth industry. We are committed to the development of the sector as we become one of the top places in the world to do science-based business. In Tees Valley, the sector contributes £450million of economic output, with over 600 businesses employing more than 5,000 people.

Investor Confidence

Internationally recognised companies such as FUJIFILM Diosynth Biotechnologies and the Centre for Process Innovation (CPI) are continuing to invest heavily in Tees Valley, as well as SMEs such as Hart Biologicals and Cambridge Research Biochemicals.

National Biologics Manufacturing Centre

CPI is the UK’s national technology and innovation centre for the process manufacturing industries.  Located in Darlington, CPI’s National Biologics Manufacturing Centre combines state-of-the-art facilities and technical expertise to support the growth and development of the UK biologics industry and supply chain.  The National Biologics Manufacturing Centre collaborates with large corporations, SMEs, academia and charities to enable the delivery of innovative manufacturing solutions and to accelerate the cost effective, safe and high-quality manufacture of life-changing biologic therapies.

National Horizons Centre

Led by Teesside University, the National Horizons Centre is a purpose-built centre designed to address UK technology sector growth through the provision of world class facilities and equipment for hands-on training. It addresses skills shortages in the biosciences, biotechnology, health technology and related sectors by growing the number of  technicians, graduates and post-graduates and through continuous professional development for those re-training or in employment. In collaboration with the private sector, it also enables growth through industry-led research and innovation.

State-of-the-Art Facilities

The National Horizons Centre is a £22million state-of-the-art bioscience education, training, research and innovation facility directly addresses the growth potential in the life sciences sector. It will specialise in providing the full range of skills for the biosciences sector and in applying digital technologies to improve performance and productivity and foster breakthrough ideas.

Harnessing Teesside University’s cutting-edge expertise in digital technologies and its links with the Digital Catapult, the National Horizons Centre will play a pivotal role in tackling the rapid growth challenges facing the sector. It will collaborate with industry partners, such as FujiFilm Diosynth Technologies and CPI, to address skills needs and create and provide access to world-class research and facilities that enable new discoveries and opportunities.

Teesside University

As well as leading the National Horizons Centre development, Teesside University also produces 2,000 health and social care students each year, and a further 1,700 students across biological, biochemistry, pharmaceutical and engineering courses. The university supports nearly 3,000 jobs and has an excellent record of employer engagement.

Clinical Trials

Tees Valley has four NHS trusts and a strong track record of delivering clinical trials, with around 5,500 patients recruited annually and the National Institute for Health Research has ranked the South Tees Trust in the top 10% of NHS trusts in the country for the number of participants recruited to trials. This clinical research is augmented by strong relationships between academic institutions, industry and the NHS and its supportive innovation network drives and helps to fund collaborative research and development for patient gain.

YOU CAN FIND OUT MORE BY DOWNLOADING OUR HEALTHCARE AND LIFE SCIENCES INVESTMENT PROSPECTUS

Click to download